Sep 16, 2026 09:33AM
Sep 14, 2026 07:34AM
Aug 10, 2026 04:26AM
Aug 6, 2026 04:08PM
May 12, 2026 04:08PM
May 7, 2026 08:00AM
May 7, 2026 08:00AM Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
Apr 30, 2026 08:00AM
Apr 28, 2026 08:02AM
Apr 28, 2026 08:00AM
Mar 19, 2026 04:12PM
Mar 11, 2026 01:01PM
Mar 11, 2026 01:01PM
Mar 6, 2026 08:31AM Solid Biosciences raises $240 million in private placement
Mar 6, 2026 08:31AM
Mar 6, 2026 08:30AM
Mar 6, 2026 08:30AM
Feb 10, 2026 04:47AM
Feb 9, 2026 08:00AM
Feb 9, 2026 08:00AM
Jan 13, 2026 04:15PM Solid Biosciences advances gene therapy trials across muscle diseases
Jan 13, 2026 04:15PM
Jan 12, 2026 04:15PM
Jan 12, 2026 04:15PM
Jan 12, 2026 08:05AM
Jan 12, 2026 08:05AM
Dec 22, 2025 07:06AM
Dec 17, 2025 05:31AM Solid Biosciences (SLDB) in Good Position with Capsid, Dystrophin - Citizens
Dec 16, 2025 04:51PM
Dec 16, 2025 04:51PM
Dec 8, 2025 08:00AM
Dec 1, 2025 08:04AM
Dec 1, 2025 08:00AM
Nov 17, 2025 08:04AM
Nov 17, 2025 08:00AM Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101
Nov 6, 2025 08:04AM
Nov 6, 2025 08:00AM
Nov 3, 2025 04:05PM
Oct 24, 2025 08:29AM
Oct 1, 2025 08:00AM
Sep 25, 2025 08:00AM
Sep 23, 2025 08:00AM Solid Biosciences licenses gene therapy capsid to Kinea Bio
Sep 23, 2025 08:00AM
Sep 12, 2025 04:10AM
Aug 14, 2025 04:22AM
Aug 12, 2025 04:07PM
Jul 23, 2025 08:00AM
Jul 23, 2025 08:00AM
Jul 17, 2025 04:50AM Citi Opens Catalyst Call on Solid Biosciences (SLDB)
Jul 8, 2025 04:05PM

334,271 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All